ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,149,762 | -13.6% | 19,803 | -19.9% | 0.01% | -11.1% |
Q2 2023 | $1,330,408 | +55.9% | 24,715 | +15.0% | 0.01% | +50.0% |
Q1 2023 | $853,503 | -4.1% | 21,488 | -2.8% | 0.01% | -14.3% |
Q4 2022 | $889,727 | +125037.4% | 22,116 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $711 | -99.9% | 22,116 | -8.8% | 0.01% | 0.0% |
Q2 2022 | $719,000 | +7.6% | 24,249 | +2.1% | 0.01% | +50.0% |
Q1 2022 | $668,000 | -34.3% | 23,750 | +7.8% | 0.00% | -20.0% |
Q4 2021 | $1,016,000 | +52.6% | 22,040 | +8.6% | 0.01% | +25.0% |
Q3 2021 | $666,000 | -41.4% | 20,290 | -37.4% | 0.00% | -42.9% |
Q2 2021 | $1,136,000 | +58.2% | 32,408 | +63.2% | 0.01% | +40.0% |
Q1 2021 | $718,000 | +16.0% | 19,860 | -6.8% | 0.01% | 0.0% |
Q4 2020 | $619,000 | -26.8% | 21,300 | -29.0% | 0.01% | -28.6% |
Q3 2020 | $846,000 | +25.7% | 29,995 | +44.1% | 0.01% | +16.7% |
Q2 2020 | $673,000 | -20.6% | 20,810 | 0.0% | 0.01% | -40.0% |
Q1 2020 | $848,000 | -33.9% | 20,810 | 0.0% | 0.01% | +25.0% |
Q4 2019 | $1,283,000 | -25.5% | 20,810 | -11.9% | 0.01% | -33.3% |
Q3 2019 | $1,721,000 | +12.9% | 23,610 | +27.3% | 0.01% | 0.0% |
Q2 2019 | $1,525,000 | +198.4% | 18,550 | +155.9% | 0.01% | +140.0% |
Q1 2019 | $511,000 | +56.7% | 7,250 | 0.0% | 0.01% | +66.7% |
Q4 2018 | $326,000 | -6.3% | 7,250 | +17.9% | 0.00% | +50.0% |
Q3 2018 | $348,000 | -7.2% | 6,150 | +9.6% | 0.00% | -33.3% |
Q2 2018 | $375,000 | +14.7% | 5,611 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $327,000 | -9.7% | 5,611 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $362,000 | +22.7% | 5,611 | 0.0% | 0.00% | +100.0% |
Q3 2017 | $295,000 | +5.0% | 5,611 | -1.0% | 0.00% | -66.7% |
Q1 2017 | $281,000 | -18.1% | 5,666 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $343,000 | -8.8% | 5,666 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $376,000 | +30.6% | 5,666 | +9.7% | 0.00% | +33.3% |
Q2 2016 | $288,000 | +23.6% | 5,166 | 0.0% | 0.00% | +50.0% |
Q4 2015 | $233,000 | -28.7% | 5,166 | -37.5% | 0.00% | -33.3% |
Q3 2015 | $327,000 | -58.4% | 8,266 | -34.7% | 0.00% | -50.0% |
Q2 2015 | $786,000 | -18.2% | 12,666 | -17.6% | 0.01% | -14.3% |
Q1 2015 | $961,000 | – | 15,366 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |